APA (7th ed.) Citation

L, D., HHH, E., C, P., A, D., M, P., C, T., . . . K, E. (2022). Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines. Journal of cancer research and clinical oncology, 148(6), 1313. https://doi.org/10.1007/s00432-022-03914-5

Chicago Style (17th ed.) Citation

L, Donix, Erb HHH, Peitzsch C, Dubrovska A, Pfeifer M, Thomas C, Fuessel S, and Erdmann K. "Acquired Resistance to Irradiation or Docetaxel Is Not Associated with Cross-resistance to Cisplatin in Prostate Cancer Cell Lines." Journal of Cancer Research and Clinical Oncology 148, no. 6 (2022): 1313. https://doi.org/10.1007/s00432-022-03914-5.

MLA (9th ed.) Citation

L, Donix, et al. "Acquired Resistance to Irradiation or Docetaxel Is Not Associated with Cross-resistance to Cisplatin in Prostate Cancer Cell Lines." Journal of Cancer Research and Clinical Oncology, vol. 148, no. 6, 2022, p. 1313, https://doi.org/10.1007/s00432-022-03914-5.